Replies to post #28165 on Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[mdropp]

Sounds like it is a given that further studies will be done.
Good news.

"Future studies will characterize the treatment window, the time course of treatment needed, and the dose needed to achieve therapeutic levels of anatabine in humans after injury."